Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Molecular Diversity|September 24, 2004
Defining the antigenic structure of human GM-CSF and its implications for receptor interaction and therapeutic treatmentsMarcos Oggero, Ronald Frank, Marina Etcheverrigaray, et al.
Biochimie|April 21, 2010
Influence of carbohydrates on the stability and structure of a hyperglycosylated human interferon alpha muteinNatalia Ceaglio, Marina Etcheverrigaray, Ricardo Kratje, et al.
Vaccine|March 18, 2014
Rabies virus-like particles expressed in HEK293 cellsDiego Fontana, Ricardo Kratje, Marina Etcheverrigaray, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
Development of Rabies Virus-Like Particles for Vaccine Applications: Production, Characterization, and Protection StudiesDiego Fontana, Marina Etcheverrigaray, Ricardo Kratje, et al.
Vaccine|June 30, 2009
Suspension-Vero cell cultures as a platform for viral vaccine productionCristian Paillet, Guillermina Forno, Ricardo Kratje, et al.
Protein Expression and Purification|June 27, 2013
A versatile ionic strength sensitive tag from a human GM-CSF-derived linear epitopeNorma Perotti, Marina Etcheverrigaray, Ricardo Kratje, et al.
Biotechnology Letters|September 28, 2006
Rational selection of an antibody probe to detect the heterogeneous collection of CHO-derived rhGM-CSF glycoformsMarcos Oggero, Guillermina Forno, Ricardo Kratje, et al.
Vaccine|March 18, 2014
Target cells for antibodies detection in rabies vaccine controlDiego Fontana, Claudio Prieto, Ricardo Kratje, et al.
Protein Expression and Purification|January 17, 2017
A highly efficient modified human serum albumin signal peptide to secrete proteins in cells derived from different mammalian speciesCarolina Attallah, Marina Etcheverrigaray, Ricardo Kratje, et al.
Vaccine|April 15, 2015
Immunogenic virus-like particles continuously expressed in mammalian cells as a veterinary rabies vaccine candidateDiego Fontana, Ricardo Kratje, Marina Etcheverrigaray, et al.
Pageof 5